Federal prosecutors open criminal probe into MLBPA's Players Way venture amid allegations of self-dealing and misuse of union resources.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Federal prosecutors open criminal probe into MLBPA's Players Way venture amid allegations of self-dealing and misuse of union resources.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.